BRIEF published on 11/04/2025 at 07:40, 6 months 12 days ago Evrotrust lève 6,6 millions d'euros pour son expansion européenne Expansion Européenne Identité Numérique EIDAS 2.0 Evrotrust 3TS Capital Partners
BRIEF published on 11/04/2025 at 07:35, 6 months 12 days ago SFC Energy Secures EUR 7.5 Million Order for EFOY Pro Fuel Cells Sustainability Fuel Cells Surveillance Refurbishment Off-grid Power
BRIEF published on 11/04/2025 at 07:35, 6 months 12 days ago SFC Energy décroche une commande de 7,5 millions d'euros pour des piles à combustible EFOY Pro Durabilité Piles À Combustible Surveillance Remise À Neuf Énergie Hors Réseau
BRIEF published on 11/04/2025 at 07:35, 6 months 12 days ago R. STAHL Reports Q3 2025 Results Amidst Subdued Demand Cost-cutting Measures Sales Forecast EBITDA Growth Nine-month Figures Demand Decrease
BRIEF published on 11/04/2025 at 07:35, 6 months 12 days ago R. STAHL publie ses résultats du troisième trimestre 2025 dans un contexte de demande atone Mesures De Réduction Des Coûts Croissance De L'EBITDA Chiffres Sur Neuf Mois Prévisions Des Ventes Diminution De La Demande
BRIEF published on 11/04/2025 at 07:35, 6 months 12 days ago Circus SE Launches Defence Subsidiary for AI Robotics Expansion Autonomous Systems AI Robotics Defence Expansion European Defence Strategic Launch
BRIEF published on 11/04/2025 at 07:35, 6 months 12 days ago Circus SE lance une filiale de défense pour développer ses activités en robotique et intelligence artificielle Robotique IA Systèmes Autonomes Défense Européenne Expansion De La Défense Lancement Stratégique
BRIEF published on 11/04/2025 at 07:35, 6 months 12 days ago MaaT Pharma Third Quarter 2025 Financial Results and Financing Update Financial Results MaaT Pharma European Medicines Agency Xervyteg® Clinigen Partnership
BRIEF published on 11/04/2025 at 07:35, 6 months 12 days ago MaaT Pharma : Résultats financiers et mise à jour du financement pour le troisième trimestre 2025 Résultats Financiers MaaT Pharma Agence Européenne Des Médicaments Xervyteg® Partenariat Clinigen
BRIEF published on 11/04/2025 at 07:26, 6 months 12 days ago UBS AG Releases Third-Quarter 2025 Financial Report Investor Relations Financial Report Transparency UBS 3Q25
Published on 05/16/2026 at 01:15, 23 hours 31 minutes ago Findev Inc. Announces a New Member of the Board of Directors
Published on 05/16/2026 at 00:00, 1 day ago Onco-Innovations Strengthens Quality Testing for Lead PNKP Inhibitor Drug Candidate
Published on 05/15/2026 at 23:10, 1 day 1 hour ago Golden Minerals Reports First Quarter 2026 Financial Results
Published on 05/15/2026 at 23:00, 1 day 1 hour ago Jericho Energy Ventures Announces Transition to Semi-Annual Reporting to Enhance Efficiency
Published on 05/16/2026 at 16:08, 8 hours 37 minutes ago The publication of the audited financial statements for 2025 will be postponed to 12 June 2026 – management does not expect any significant changes to the figures already published
Published on 05/15/2026 at 20:10, 1 day 4 hours ago CPIPG Communication Concerning Voluntary Offer on NEXT RE Shares – Provisional Results Announcement
Published on 05/15/2026 at 18:10, 1 day 6 hours ago Virtual Science AI launches first AI-driven competitor activity tracking platform to support pharma asset launch success
Published on 05/15/2026 at 15:08, 1 day 9 hours ago Notice of exercise of early redemption option of the subordinated note ISIN : FR0010203026
Published on 05/15/2026 at 15:00, 1 day 9 hours ago Exercice de l’option de remboursement de l'instrument subordonné FR0010203026
Published on 05/15/2026 at 10:09, 1 day 14 hours ago Groupe Crit : Modalités de mise à disposition des documents préparatoires à l’Assemblée Générale Mixte du 05 juin 2026.
Published on 05/14/2026 at 09:03, 2 days 15 hours ago Coup d'envoi pour les carrières dans l'esport : 65% de la population mondiale réclame plus de formations et de parcours professionnels pour le jeu vidéo de compétition
Published on 05/13/2026 at 18:02, 3 days 6 hours ago ALTAREA : Assemblée Générale Mixte du 4 juin 2026 MODALITES DE MISE A DISPOSITION DES DOCUMENTS PREPARATOIRES
